• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-1抗胰蛋白酶是炎症和免疫调节的一个潜在靶点(综述)。

α‑1 Antitrypsin is a potential target of inflammation and immunomodulation (Review).

作者信息

Wang Tiantian, Shuai Peimeng, Wang Qingyu, Guo Caimao, Huang Shuqi, Li Yuanyuan, Wu Wenyu, Yi Lan

机构信息

Hengyang Key Laboratory of Cellular Stress Biology, Institute of Cytology and Genetics, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China.

Hengyang Key Laboratory of Cellular Stress Biology, Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China.

出版信息

Mol Med Rep. 2025 Apr;31(4). doi: 10.3892/mmr.2025.13472. Epub 2025 Feb 28.

DOI:10.3892/mmr.2025.13472
PMID:40017119
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11881679/
Abstract

α‑1 Antitrypsin (AAT) is an acute phase protein encoded by the gene. This multifunctional protein serves several roles, including anti‑inflammatory, antibacterial, antiapoptotic and immune regulatory functions. The primary role of AAT is to protect tissues and organs from protease‑induced damage due to its function as a serine protease inhibitor. AAT is associated with the development of lung inflammation, liver inflammation and immune‑mediated inflammatory diseases, which are influenced by environmental and genetic factors. For instance, AAT acts as an anti‑inflammatory protein to prevent and reverse type I diabetes. The present study briefly reviewed the molecular properties and mechanisms of AAT, as well as advances in the study of lung, liver and inflammatory diseases associated with AAT. The potential of AAT as a diagnostic and therapeutic target for inflammatory and immune‑mediated inflammatory diseases was reviewed. In addition, the damaging and protective effects of AAT, and its effects on organ function were discussed.

摘要

α-1抗胰蛋白酶(AAT)是一种由该基因编码的急性期蛋白。这种多功能蛋白具有多种作用,包括抗炎、抗菌、抗凋亡和免疫调节功能。AAT的主要作用是作为一种丝氨酸蛋白酶抑制剂,保护组织和器官免受蛋白酶诱导的损伤。AAT与肺部炎症、肝脏炎症和免疫介导的炎症性疾病的发生发展相关,这些疾病受环境和遗传因素影响。例如,AAT作为一种抗炎蛋白可预防和逆转I型糖尿病。本研究简要综述了AAT的分子特性和机制,以及与AAT相关的肺部、肝脏和炎症性疾病的研究进展。综述了AAT作为炎症和免疫介导的炎症性疾病诊断和治疗靶点的潜力。此外,还讨论了AAT的损伤和保护作用及其对器官功能的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf2/11881679/e9cae6155a81/mmr-31-04-13472-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf2/11881679/cdcb835fece9/mmr-31-04-13472-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf2/11881679/e9cae6155a81/mmr-31-04-13472-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf2/11881679/cdcb835fece9/mmr-31-04-13472-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf2/11881679/e9cae6155a81/mmr-31-04-13472-g01.jpg

相似文献

1
α‑1 Antitrypsin is a potential target of inflammation and immunomodulation (Review).α-1抗胰蛋白酶是炎症和免疫调节的一个潜在靶点(综述)。
Mol Med Rep. 2025 Apr;31(4). doi: 10.3892/mmr.2025.13472. Epub 2025 Feb 28.
2
Alpha-1 Antitrypsin as a Regulatory Protease Inhibitor Modulating Inflammation and Shaping the Tumor Microenvironment in Cancer.α-1抗胰蛋白酶作为一种调节性蛋白酶抑制剂,在癌症中调节炎症并塑造肿瘤微环境。
Cells. 2025 Jan 10;14(2):88. doi: 10.3390/cells14020088.
3
Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions.α-1-抗胰蛋白酶缺乏症:遗传变异、临床表现和治疗干预。
Mutat Res Rev Mutat Res. 2017 Jul;773:14-25. doi: 10.1016/j.mrrev.2017.03.001. Epub 2017 Mar 18.
4
Safety of Intravenous Administration of an AAV8 Vector Coding for an Oxidation-Resistant Human α1-Antitrypsin for the Treatment of α1-Antitrypsin Deficiency.静脉注射编码抗氧化人α1-抗胰蛋白酶的 AAV8 载体治疗 α1-抗胰蛋白酶缺乏症的安全性。
Hum Gene Ther. 2023 Feb;34(3-4):139-149. doi: 10.1089/hum.2022.192.
5
Augmentation therapy with alpha1-antitrypsin: novel perspectives.α1-抗胰蛋白酶增强疗法:新视角
Cardiovasc Hematol Disord Drug Targets. 2013 Aug;13(2):90-8. doi: 10.2174/1871529x11313020002.
6
Immune-modulating effects of alpha-1 antitrypsin.α1抗胰蛋白酶的免疫调节作用
Biol Chem. 2014 Oct;395(10):1187-93. doi: 10.1515/hsz-2014-0161.
7
Expanding the clinical indications for α(1)-antitrypsin therapy.拓展 α(1)-抗胰蛋白酶疗法的临床适应证。
Mol Med. 2012 Sep 7;18(1):957-70. doi: 10.2119/molmed.2011.00196.
8
Therapeutic compositions and uses of alpha1-antitrypsin: a patent review (2012 - 2015).α1-抗胰蛋白酶的治疗组合物及用途:专利综述(2012 - 2015年)
Expert Opin Ther Pat. 2016 May;26(5):581-9. doi: 10.1517/13543776.2016.1165210. Epub 2016 Mar 25.
9
Alpha-1 Antitrypsin Attenuates M1 Microglia-Mediated Neuroinflammation in Retinal Degeneration.α-1抗胰蛋白酶减轻视网膜变性中M1小胶质细胞介导的神经炎症。
Front Immunol. 2018 May 30;9:1202. doi: 10.3389/fimmu.2018.01202. eCollection 2018.
10
Increased outer arm and core fucose residues on the N-glycans of mutated alpha-1 antitrypsin protein from alpha-1 antitrypsin deficient individuals.来自α-1抗胰蛋白酶缺乏个体的突变α-1抗胰蛋白酶蛋白的N-聚糖上,外侧臂和核心岩藻糖残基增加。
J Proteome Res. 2014 Feb 7;13(2):596-605. doi: 10.1021/pr400752t. Epub 2013 Dec 13.

本文引用的文献

1
Plasma levels of α-antitrypsin-derived C-terminal peptides in PiMM and PiZZ COPD patients.PiMM和PiZZ型慢性阻塞性肺疾病患者血浆中α-抗胰蛋白酶衍生的C末端肽水平。
ERJ Open Res. 2023 Dec 4;9(6). doi: 10.1183/23120541.00329-2023. eCollection 2023 Nov.
2
Novel Therapeutic Approaches to Liver Fibrosis Based on Targeting Oxidative Stress.基于靶向氧化应激的肝纤维化新型治疗方法
Antioxidants (Basel). 2023 Aug 5;12(8):1567. doi: 10.3390/antiox12081567.
3
Mesenchymal stromal cells and alpha-1 antitrypsin have a strong synergy in modulating inflammation and its resolution.
间充质基质细胞和α-1 抗胰蛋白酶在调节炎症及其消退方面具有很强的协同作用。
Theranostics. 2023 May 8;13(9):2843-2862. doi: 10.7150/thno.83942. eCollection 2023.
4
Loss of in Mice Leads to Altered Gene Expression in Inflammatory and Metabolic Pathways.小鼠中缺失 导致炎症和代谢途径中基因表达的改变。
Int J Mol Sci. 2022 Sep 9;23(18):10425. doi: 10.3390/ijms231810425.
5
Cigarette smoke exposed airway epithelial cell-derived EVs promote pro-inflammatory macrophage activation in alpha-1 antitrypsin deficiency.香烟烟雾暴露的气道上皮细胞衍生的 EVs 促进α-1 抗胰蛋白酶缺乏症中促炎巨噬细胞的活化。
Respir Res. 2022 Sep 6;23(1):232. doi: 10.1186/s12931-022-02161-z.
6
Alpha-1 Antitrypsin Reduces Disease Progression in a Mouse Model of Charcot-Marie-Tooth Type 1A: A Role for Decreased Inflammation and ADAM-17 Inhibition.α-1 抗胰蛋白酶可减少 1A 型腓骨肌萎缩症小鼠模型的疾病进展:减少炎症和 ADAM-17 抑制的作用。
Int J Mol Sci. 2022 Jul 3;23(13):7405. doi: 10.3390/ijms23137405.
7
Senescence: Pathogenic Driver in Chronic Obstructive Pulmonary Disease.衰老:慢性阻塞性肺疾病的致病驱动因素。
Medicina (Kaunas). 2022 Jun 17;58(6):817. doi: 10.3390/medicina58060817.
8
A Review of Alpha-1 Antitrypsin Binding Partners for Immune Regulation and Potential Therapeutic Application.α1-抗胰蛋白酶结合蛋白的免疫调节作用及潜在治疗应用研究进展
Int J Mol Sci. 2022 Feb 23;23(5):2441. doi: 10.3390/ijms23052441.
9
Gamma-tocotrienol, a radiation countermeasure, reverses proteomic changes in serum following total-body gamma irradiation in mice.γ-生育三烯酚,一种辐射对策物,可逆转全身γ 射线照射后小鼠血清中的蛋白质组变化。
Sci Rep. 2022 Mar 1;12(1):3387. doi: 10.1038/s41598-022-07266-5.
10
The Mechanism of Mitochondrial Injury in Alpha-1 Antitrypsin Deficiency Mediated Liver Disease.α-1 抗胰蛋白酶缺乏症相关肝疾病中线粒体损伤的机制。
Int J Mol Sci. 2021 Dec 9;22(24):13255. doi: 10.3390/ijms222413255.